Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 4,300 shares, an increase of 207.1% from the December 15th total of 1,400 shares. Based on an average trading volume of 11,200 shares, the days-to-cover ratio is currently 0.4 days.
Invesco Nasdaq Biotechnology ETF Stock Performance
NASDAQ IBBQ traded up $0.37 during trading hours on Wednesday, hitting $21.58. 4,850 shares of the company traded hands, compared to its average volume of 6,694. The business’s 50-day moving average is $22.45 and its 200-day moving average is $23.33. The stock has a market capitalization of $38.20 million, a price-to-earnings ratio of 17.39 and a beta of 0.61. Invesco Nasdaq Biotechnology ETF has a twelve month low of $20.14 and a twelve month high of $24.84.
Invesco Nasdaq Biotechnology ETF Dividend Announcement
The company also recently announced a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were issued a $0.0619 dividend. The ex-dividend date of this dividend was Monday, December 23rd.
Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Further Reading
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- What is the Nasdaq? Complete Overview with History
- How Do Stock Buybacks Affect Shareholders?
- How to Invest in Small Cap StocksĀ
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.